OR WAIT 15 SECS
September 21, 2020
Article
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
July 21, 2020
Some patients affected by COVID-19 may be concerned about hyposmia (reduced ability to smell) or anosmia (loss of smell) that they experience after contracting the virus.
July 10, 2020
Pharmacists can counsel patients with GERD on strategies to address their symptoms.
July 01, 2020
Pharmacists can and must play an active role in guiding patients on the selection of laxatives which are supported by sound evidence.